Intriguingly, statins, which block 3-hydroxy-3-methylglutaryl CoA-reductase, were found to suppress MPO expression in macrophages at the gene and protein levels [164] and reduce serum MPO levels in diabetic hemodialysis patients [149] and patients with acute coronary syndrome [148]. This evidence concerns the gene MPO and acute coronary syndrome.